Can a Parasite-Fighting drug halt a nearly 100% fatal disease?
NCT ID NCT07182305
First seen Nov 01, 2025 · Last updated May 09, 2026 · Updated 23 times
Summary
This study tested the drug albendazole in 194 people with early-stage alveolar echinococcosis, a parasitic liver disease that is almost always fatal within 10-15 years if untreated. The goal was to see if the drug could stop the parasite lesions from growing. Albendazole is known to control the disease but does not cure it, so patients need to take it long-term.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALVEOLAR ECHINOCOCCOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of disease prevention and sanitary - epidemiological surveillance
Bishkek, Kyrgyzstan
Conditions
Explore the condition pages connected to this study.